G5 reported weaker than expected growth in Q4 2023 and while recent and upcoming game launches support gradually improving topline, we have lowered our near-term growth assumptions. Although the company’s announced cost optimizations mitigate the impact of a lower topline to some extent, we have reduced our EBIT estimates by c14-18% for 2024-25E.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases